feed
view company updates
tools
perform investment research
network
join events & discussions
advisory
about us
Redeye Capital
Nuevolution: Competitor scraps RORyt project
Research Note
2018-04-30
18:24
Allergan announced in their Q1 report that they are writing off their RORyt inhibitor project for psoriasis.
MS
Mathias Spinnars
Sign up for free to continue
Sign up with Email
Sign in with Google
Already a member?
Sign in
Disclosures and disclaimers
Premium Plan required to unlock
Unlock companies to access
more high quality research.
View Plans